Literature DB >> 33457199

Acute onset systemic lupus erythematosus interstitial lung disease: A case report.

Hiroshi Kobe1, Machiko Arita1, Keiichiro Kadoba2, Takashi Niwa3, Fumiaki Tokioka1, Tadashi Ishida1.   

Abstract

A 40-year-old Japanese man was diagnosed with systemic lupus erythematosus. Chest computed tomography showed patchy consolidation in both lungs. A cryobiopsy and bronchoalveolar lavage showed organizing pneumonia, not acute lupus pneumonia or diffuse alveolar hemorrhage. This case demonstrates the usefulness of cryobiopsy for the management of systemic lupus erythematosus interstitial lung disease.
© 2021 The Authors. Published by Elsevier Ltd.

Entities:  

Keywords:  ALP, acute lupus pneumonitis; Acute lupus pneumonia; BALF, bronchoalveolar lavage fluid; CT, computed tomography; Cryobiopsy; DAD, diffuse alveolar damage; DAH, diffuse alveolar hemorrhage; Diffuse alveolar hemorrhage; OP, organizing pneumonia; SLB, surgical lung biopsy; SLE, systemic lupus erythematosus; SLE-ILD, systemic lupus erythematosus interstitial lung disease; Systemic lupus erythematosus; Systemic lupus erythematosus interstitial lung disease

Year:  2021        PMID: 33457199      PMCID: PMC7797902          DOI: 10.1016/j.rmcr.2020.101329

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Introduction

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by a wide spectrum of clinical manifestations, including cardiac, vascular, renal, mucocutaneous, and pulmonary involvement [1]. Pulmonary involvement includes acute lupus pneumonitis (ALP) and diffuse alveolar hemorrhage (DAH), which are the most severe conditions [2,3]. Accurate diagnosis is important for treatment planning and prolonging survival. However, due to the poor general condition of patients at onset, it is not always possible to perform sufficient investigations. A case of acute onset SLE interstitial lung disease (SLE-ILD), which was diagnosed as organizing pneumonia (OP), not ALP or DAH, by cryobiopsy and bronchoalveolar lavage fluid (BALF) examinations and started on appropriate treatment, is presented. This case demonstrates the usefulness of cryobiopsy to determine appropriate treatment for acute onset SLE-ILD in a low invasive way.

Case report

A 40-year-old Japanese man visited the emergency department with a two-week history of fever, cough, shortness of breath, and chest pain. He had a more than a one-and-a-half-year history of skin ulcers (Fig. 1a and b) on both forearms and photosensitivity and erythema on the cheek and neck (Fig. 1c and d) since the previous summer. On physical examination, fine crackles were heard in both lungs.
Fig. 1

Discoid lupus erythematosus on both forearms (a, b). Photosensitivity and erythema on the cheek and neck (c, d).

Discoid lupus erythematosus on both forearms (a, b). Photosensitivity and erythema on the cheek and neck (c, d). The chest X-ray (Fig. 2a) showed bilateral diffuse infiltrates and cardiomegaly. On chest computed tomography (CT) (Fig. 2b and c) many spots or nodular ground glass shadows were evident in both lungs, and a pleural effusion was seen on the right side. Laboratory tests showed (Table 1) lymphopenia, anti-double-stranded DNA-positive, and anti-nuclear antibody-positive. SLE was diagnosed based on the above results. A skin biopsy showed the findings of discoid lupus, with shedding of epidermal cells and neutrophilic infiltration, and the subcutaneous fatty tissue was lost and fibrotic.
Fig. 2

Chest X-ray on admission shows consolidation mainly of the left lung (a). Chest CT shows consolidation of the left lung (b,c).

Table 1

Laboratory findings on admission and bronchoalveolar lavage fluid (BALF) and pulmonary function test (PFT) findings.

Laboratory findingsBALF
WBC(/μL)4200CRP(㎎/dL)1.55Total cell count(/mL)1.1 × 106
Neutro(%)68.0C3(㎎/dL)81.8Macrophages(%)56.0
Eos(%)3.0C4(㎎/dL)22.2lymphocytes(%)42.0
Lymph(%)18.0CH50(U/mL)48.0Neutrophil(%)2.0
Mono(%)11.0KL-6(U/mL)250Cytologynegative
Hb(g/dL)12.2ANA80Culturenormal flora
PLT(/μL)24.9 × 104Homo±Pneumocystis PCRnegative
Alb(g/dL)3.0Nucleola+Cytomegalovirus PCRnegative
AST(U/L)28Cyto+
ALT(U/L)22ds-DNA ELISA(IU/mL)23.0
LDH(U/L)282ds-DNA RIA(IU/mL)7.8
BUN(㎎/dL)12SS-A antibodynegative
CRE(㎎/dL)0.68SS-B antibodynegative
eGFR(mL/min/1.73m2)102.6ANCAnegative
Na(㎜ol/L)135Urinary protein
K(㎜ol/L)4.1Urinary occult blood
Ca(mg/dL)8.8Urinary sugar

Alb: Albumin, ANA: Anti-nuclear antibody, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, BUN: Blood urea nitrogen, Ca: Calcium, CH50: 50% Hemolytic unit of complement, CRE: Creatinine, CRP: C-reactive protein, Cyto: Cytoplasmic, C3: Complement 3, C4: Complement 4, ds-DNA: Anti-double-stranded DNA, eGFR: Estimated glomerular filtration rate, Eos: Eosinophil, Hb: Hemoglobin, Homo: Homogeneous, LDH: Lactate dehydrogenase, Lymph: Lymphocyte, K: Potassium, Mono: Monocyte, Na: Sodium Neutro: Neutrophil, PCR: Polymerase chain reaction, PLT: Platelets, WBC: White blood cell.

Chest X-ray on admission shows consolidation mainly of the left lung (a). Chest CT shows consolidation of the left lung (b,c). Laboratory findings on admission and bronchoalveolar lavage fluid (BALF) and pulmonary function test (PFT) findings. Alb: Albumin, ANA: Anti-nuclear antibody, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, BUN: Blood urea nitrogen, Ca: Calcium, CH50: 50% Hemolytic unit of complement, CRE: Creatinine, CRP: C-reactive protein, Cyto: Cytoplasmic, C3: Complement 3, C4: Complement 4, ds-DNA: Anti-double-stranded DNA, eGFR: Estimated glomerular filtration rate, Eos: Eosinophil, Hb: Hemoglobin, Homo: Homogeneous, LDH: Lactate dehydrogenase, Lymph: Lymphocyte, K: Potassium, Mono: Monocyte, Na: Sodium Neutro: Neutrophil, PCR: Polymerase chain reaction, PLT: Platelets, WBC: White blood cell. A cryobiopsy and BAL were performed to rule out ALP and DAH because of the acute clinical course of the SLE-associated pulmonary disease. Based on the gross findings of the BALF and no findings of hemosiderin-laden macrophages on histopathology and cytology, DAH was ruled out (Fig. 3a). The cell fraction of BALF was lymphocyte-dominant (Table 1).
Fig. 3

Appearance of bronchoalveolar lavage fluid (A). There is no alveolar hemorrhage, since there is no sign of a gradual increase in bloodiness. Pulmonary histopathological findings of the tissues obtained by cryobiopsy (hematoxylin and eosin stain; H&E) (B–D). An excessive proliferation of granulation tissue with bronchiolar intraluminal polyps, which suggests organizing pneumonia (OP) pattern (B, C). Fibrin precipitation into the alveolar space is present, suggesting severe alveolar epithelial damage (D).

Appearance of bronchoalveolar lavage fluid (A). There is no alveolar hemorrhage, since there is no sign of a gradual increase in bloodiness. Pulmonary histopathological findings of the tissues obtained by cryobiopsy (hematoxylin and eosin stain; H&E) (B–D). An excessive proliferation of granulation tissue with bronchiolar intraluminal polyps, which suggests organizing pneumonia (OP) pattern (B, C). Fibrin precipitation into the alveolar space is present, suggesting severe alveolar epithelial damage (D). A histological analysis of the lung tissues obtained by cryobiopsy (Fig. 3b) showed OP pattern, with excessive proliferation of granulation tissue with bronchiolar intraluminal polyps, and fibrin deposition in the alveolar space showed severe alveolar damage. There were no findings of organizing diffuse alveolar damage (DAD) or acute fibrinous OP. The patient was referred to the Department of Rheumatology, and he was started on high-dose methylprednisolone and intermittent intravenous cyclophosphamide therapy. Three months later, the bilateral diffuse infiltrates had decreased on chest X-ray and chest CT (Fig. 4), and the pulmonary function tests were improved (Table 2).
Fig. 4

Chest X-ray 3 months after admission shows that consolidation has improved (a). Chest CT 3 months after admission shows that consolidation has improved (b, c).

Table 2

Pulmonary function test results.

PFTOn admission3 months later
VC(L)3.024.19
%VC(%)69.195.2
FEV1(L)2.403.22
%FEV1(%)64.285.6
FEV1% (%)79.576.8
%DLCO(%)80.973.0

DL: Diffusing capacity for carbon monoxide, FEV: Forced expiratory volume in one second, PFT: Pulmonary function test, VC: Vital capacity.

Chest X-ray 3 months after admission shows that consolidation has improved (a). Chest CT 3 months after admission shows that consolidation has improved (b, c). Pulmonary function test results. DL: Diffusing capacity for carbon monoxide, FEV: Forced expiratory volume in one second, PFT: Pulmonary function test, VC: Vital capacity.

Discussion

A case of acute onset SLE-ILD that was histopathologically diagnosed as OP by cryobiopsy was reported. DAH was suspected radiologically, and ALP was suspected clinically, but both were ruled out by the cryobiopsy and BALF examinations, and appropriate intensity treatments were performed. Enomoto et al. reported that the most frequent onset of SLE-ILD at diagnosis was chronic onset (63.6%), followed by subacute (20.0%) and acute (12.7%) [4]. The frequent patterns on high-resolution CT were NSIP + OP pattern (25%), OP pattern (22%), NSIP pattern (13%), and DAD pattern (2%). In the present case, ALP was suspected based on the acute onset, and DAH was suspected based on the chest CT findings. ALP and DAH have been described as the major forms of severe pulmonary involvement in SLE. They are characterized by the sudden onset of non-specific symptoms including dyspnea, cough, fever, pleuritic chest pain, and, occasionally, hemoptysis [5]. DAH is usually diagnosed by BALF examination when an increasingly or persistently bloody BALF return is noted. ALP is generally a histological diagnosis that has been described as DAD with or without alveolar hemorrhage and capillaritis. In the present patient, ALP and DAH were suspected due to the clinical symptoms and radiological findings, but they were ruled out by BALF and cryobiopsy examinations. Treatment with high-dose methylprednisolone and intermittent intravenous cyclophosphamide was started. In SLE-ILD, surgical lung biopsies have generally not been performed because of the patients’ poor respiratory status. Enomoto et al. reported that, of 55 SLE-ILD patients, only 9 underwent lung biopsy [4]. Although cryobiopsy is a technique similar to forceps biopsy, cryobiopsy could obtain sufficient specimens to contribute to a definitive diagnosis, better than forceps biopsy. Some reports showed that cryobiopsy has a higher diagnostic yield than conventional forceps biopsy [6], with high levels of agreement between cryobiopsy and surgical lung biopsy (SLB) for both histopathological interpretation and multidisciplinary discussion [7]. Moreover, cryobiopsy may enable histopathological assessment even in patients with more advanced disease unsuitable for SLB [8]. In the present case, the degree of alveolar damage could be assessed by histological examination, and adequate treatment was provided. We hope that further knowledge of the relationship between the histological diagnosis of SLE-ILD and its treatment outcomes will be obtained.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author contributions (Credit roles)

Machiko Arita: conceptualization, Keiichiro Kadoba: supervision, Takashi Niwa: writing-review and editing, Fumiaki Tokioka: writing-review and editing, Tadashi Ishida: writing-review and editing.

Declaration of competing interest

None.
  8 in total

Review 1.  Pleuropulmonary manifestations of systemic lupus erythematosus.

Authors:  M P Keane; J P Lynch
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

2.  Transbronchial Cryobiopsies for Diagnosing Interstitial Lung Disease: Real-Life Experience from a Tertiary Referral Center for Interstitial Lung Disease.

Authors:  Julia Wälscher; Benjamin Groß; Ralf Eberhardt; Claus Peter Heussel; Monika Eichinger; Arne Warth; Felix Lasitschka; Felix J F Herth; Michael Kreuter
Journal:  Respiration       Date:  2018-12-14       Impact factor: 3.580

3.  Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.

Authors:  Lauren K Troy; Christopher Grainge; Tamera J Corte; Jonathan P Williamson; Michael P Vallely; Wendy A Cooper; Annabelle Mahar; Jeffrey L Myers; Simon Lai; Ellie Mulyadi; Paul J Torzillo; Martin J Phillips; Helen E Jo; Susanne E Webster; Qi T Lin; Jessica E Rhodes; Matthew Salamonsen; Jeremy P Wrobel; Benjamin Harris; Garrick Don; Peter J C Wu; Benjamin J Ng; Christopher Oldmeadow; Ganesh Raghu; Edmund M T Lau
Journal:  Lancet Respir Med       Date:  2019-09-29       Impact factor: 30.700

4.  Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial.

Authors:  Virginia Pajares; Carmen Puzo; Diego Castillo; Enrique Lerma; M Angeles Montero; David Ramos-Barbón; Oscar Amor-Carro; Angels Gil de Bernabé; Tomás Franquet; Vicente Plaza; Jürgen Hetzel; Joaquin Sanchis; Alfons Torrego
Journal:  Respirology       Date:  2014-06-01       Impact factor: 6.424

Review 5.  Pulmonary and thrombotic manifestations of systemic lupus erythematosus.

Authors:  Jeffrey J Swigris; Aryeh Fischer; Joann Gillis; Joann Gilles; Richard T Meehan; Kevin K Brown
Journal:  Chest       Date:  2008-01       Impact factor: 9.410

Review 6.  Pulmonary manifestations of systemic lupus erythematosus.

Authors:  Shikha Mittoo; Charlene D Fell
Journal:  Semin Respir Crit Care Med       Date:  2014-03-25       Impact factor: 3.119

Review 7.  Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Authors:  Farah Tamirou; Laurent Arnaud; Rosaria Talarico; Carlo Alberto Scirè; Tobias Alexander; Zahir Amoura; Tadej Avcin; Alessandra Bortoluzzi; Ricard Cervera; Fabrizio Conti; Alain Cornet; Hervé Devilliers; Andrea Doria; Micol Frassi; Micaela Fredi; Marcello Govoni; Frederic Houssiau; Ana Lladò; Carla Macieira; Thierry Martin; Laura Massaro; Maria Francisca Moraes-Fontes; Cristina Pamfil; Sabrina Paolino; Chiara Tani; Sander W Tas; Maria Tektonidou; Angela Tincani; Ronald F Van Vollenhoven; Stefano Bombardieri; Gerd Burmester; Fonseca João Eurico; Ilaria Galetti; Eric Hachulla; Ulf Mueller-Ladner; Matthias Schneider; Vanessa Smith; Maurizio Cutolo; Marta Mosca; Nathalie Costedoat-Chalumeau
Journal:  RMD Open       Date:  2018-11-27

8.  Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study.

Authors:  Noriyuki Enomoto; Ryoko Egashira; Kazuhiro Tabata; Mikiko Hashisako; Masashi Kitani; Yuko Waseda; Tamotsu Ishizuka; Satoshi Watanabe; Kazuo Kasahara; Shinyu Izumi; Akira Shiraki; Atsushi Miyamoto; Kazuma Kishi; Tomoo Kishaba; Chikatosi Sugimoto; Yoshikazu Inoue; Kensuke Kataoka; Yasuhiro Kondoh; Yutaka Tsuchiya; Tomohisa Baba; Hiroaki Sugiura; Tomonori Tanaka; Hiromitsu Sumikawa; Takafumi Suda
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.